Webb M, Magos L
Chem Biol Interact. 1978 Jun;21(2-3):215-26. doi: 10.1016/0009-2797(78)90020-0.
The kidney uptake of Hg2+ was increased by Cd2+-pretreatment when Hg2+ was given intraperitoneally but not subcutaneously. Subsequent s.c. administration of maleate increased Hg2+ release from the kidneys only if Hg2+ was given subcutaneously. Neither the effect of Cd2+, nor that of maleate, on the distribution of Hg2+ among the renal soluble protein fractions was affected by the route of Hg2+ administration. The protective effect of Cd2+-pretreatment against the nephrotoxic effect of Hg2+ was also independent of the route of Hg2+ administration. Maleate given in nephrotoxic doses removed Hg2+ and copper, but not Cd2+ from the renal metallothionein fraction. Mercury in the urine, however, was not complexed by proteins with the molecular weight of thionein, but was bound to high molecular weight proteins and diffusible molecules. These findings are discussed in relation to the role of metallothionein in the interaction between Cd2+ and Hg2+.
当腹腔注射汞离子(Hg2+)而非皮下注射时,镉离子(Cd2+)预处理会增加肾脏对Hg2+的摄取。仅在皮下注射Hg2+的情况下,随后皮下注射马来酸盐会增加肾脏中Hg2+的释放。Hg2+的给药途径不影响Cd2+或马来酸盐对Hg2+在肾脏可溶性蛋白组分中分布的影响。Cd2+预处理对Hg2+肾毒性作用的保护效果也与Hg2+的给药途径无关。给予肾毒性剂量的马来酸盐可从肾脏金属硫蛋白组分中去除Hg2+和铜,但不能去除Cd2+。然而,尿液中的汞并未与硫蛋白分子量的蛋白质结合,而是与高分子量蛋白质和可扩散分子结合。结合金属硫蛋白在Cd2+与Hg2+相互作用中的作用对这些发现进行了讨论。